Advertisement

NAFLD/NASH Medications

The NAFLD/NASH medications' page includes specific information about each of the experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).


Quick Filter

*generic or biosimilar available

E experimental

DRUG cenicriviroc
E
ABBRV. CVC
GENERIC NAME cenicriviroc
DRUG elafibranor
E
ABBRV. N/A
GENERIC NAME elafibranor
DRUG Ocaliva
E
ABBRV. OCA
GENERIC NAME obeticholic acid
DRUG selonsertib
E
ABBRV. N/A
GENERIC NAME selonsertib
DRUG emricasan
E
ABBRV. N/A
GENERIC NAME emricasan
DRUG cilofexor
E
ABBRV. N/A
GENERIC NAME N/A
DRUG firsocostat
E
ABBRV. N/A
GENERIC NAME N/A
DRUG pegbelfermin
E
ABBRV. N/A
GENERIC NAME pegbelfermin
DRUG tropifexor
E
ABBRV. N/A
GENERIC NAME tropifexor

Advertisement

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.